Drug Trial Radar · NCT07868861
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
Last checked: Nov 20, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Sep 15, 2026
Primary completion
Jan 2027
Study completion Feb 2027
Sponsor
- Lead sponsor
- Nasus PharmaIndustry
- Sponsor type
- Industry
- First posted
- Oct 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults
Conditions
- Chemotherapy-Induced Nausea and Vomiting (CINV)
- Radiotherapy-induced Nausea and Vomiting (RINV)
- Postoperative Nausea and Vomiting
Interventions
NS003 Ondansetron HCl microspheres powder for nasal applicationDrug
using nasal device (test)
Ondansetron Solution for IV infusion 8mgDrug
Available marketed formulation (reference)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ondansetron plasma concentrations over timeTime frame: Time zero (dosing) to 24 hours post dose
- CmaxTime frame: Time zero (doing) to 24 hours post dose
- TmaxTime frame: Time zero (doing) to 24 hours post dose
- Area Under the Curve (AUC)Time frame: Time zero to 24 hours post dose (several trancations over time)
- KelTime frame: From time zero (dosing) to 24 hours post dose
- ThalfTime frame: From time zero (dosing) to 24 hours post dose
- AUCt/AUCinfTime frame: From time zero (dosing) to 24 hours post dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hadassah Medical Center
Jerusalem, Israel · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.